In the News

Le Dauphine Libere
National Institute for Health Research
Lokalzeit aus Bonn (March 26, 2015)
9 News (March 9, 2015)
WDRB (March 1, 2015)
The Courier-Journal (Feb 25, 2015)
Clinica (Feb 2, 2015)
U of L Today (Jan 28, 2015)

Press Releases

Company Receives Approval to Revise CE Labeling 

August 29, 2012, Peseux, Switzerland – Pulmonx, an emerging leader in interventional pulmonology, announced today that its European notified body has granted CE approval for revised labeling of its Zephyr® Endobronchial Valve (EBV). The approval was...

Read more

IDE for Study of Zephyr® Endobronchial Valve Approved 

August 27, 2012, Redwood City, CA, USA - Pulmonx, an emerging leader in interventional pulmonology, announced today that the U.S. Food and Drug Administration (FDA) has approved its request for an Investigational Device Exemption (IDE) to...

Read more

Zephyr® Endobronchial Valve (EBV) therapy guided by Chartis®Assessment is effective in a broad range of patients.

May 10, 2012 ,Peseux, Switzerland, Pulmonx, an emerging leader in interventional pulmonology, announced today that the European Respiratory Journal has published the results of the...

Read more

New labeling clears the way for the treatment of many more patients.

January 10, 2012, Neuchâtel, Switzerland – Pulmonx SARL today announced that its European notified body has granted CE approval for expanded labeling of its Zephyr® endobronchial valve (EBV). The approval was based upon an...

Read more
US / new visitor